Literature DB >> 21105111

Medical and surgical treatment options for polycystic liver disease.

Joost P H Drenth1, Melissa Chrispijn, David M Nagorney, Patrick S Kamath, Vicente E Torres.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21105111     DOI： 10.1002/hep.24036

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  61 in total

Review 1.  Polycystic liver diseases: congenital disorders of cholangiocyte signaling.

Authors:  Mario Strazzabosco; Stefan Somlo
Journal:  Gastroenterology       Date:  2011-04-22       Impact factor: 22.682

2.  Diagnostic and therapeutic potentials of microRNAs in cholangiopathies.

Authors:  Indsey Kennedy; Heather Francis; Fanyin Meng; Shannon Glaser; Gianfranco Alpini
Journal:  Liver Res       Date:  2017-04-26

3.  Isolated polycystic liver disease and aneurism: a case report.

Authors:  Nikolaos Fassiadis; Sofia Lampaki; Paul Zarogoulidis; Drosos Tsavlis; Theodora Tsiouda; Ioanna Kougioumtzi; Nikolaos Machairiotis; Pavlos Pavlidis; Charalampos Charalampidis; Kosmas Tsakiridis
Journal:  Ann Transl Med       Date:  2016-05

Review 4.  Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases.

Authors:  Bassam Abu-Wasel; Caolan Walsh; Valerie Keough; Michele Molinari
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

5.  Effect of tolvaptan in a patient with autosomal dominant polycystic kidney disease after living donor liver transplantation.

Authors:  Kiyotaka Uchiyama; Kazuya Honda; Ryochi Yoshida; Yuka Kamijo; Mai Yanagi; Mineo Nakatsuka; Yoshitaka Ishibashi
Journal:  CEN Case Rep       Date:  2016-07-27

Review 6.  MicroRNAs in biliary diseases.

Authors:  Patricia Munoz-Garrido; Maite García-Fernández de Barrena; Elizabeth Hijona; Miguel Carracedo; José J G Marín; Luis Bujanda; Jesús M Banales
Journal:  World J Gastroenterol       Date:  2012-11-21       Impact factor: 5.742

7.  Somatic second-hit mutations leads to polycystic liver diseases.

Authors:  Jesús M Banales; Patricia Munoz-Garrido; Luis Bujanda
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

Review 8.  Renal transplantation in autosomal dominant polycystic kidney disease.

Authors:  Nada Kanaan; Olivier Devuyst; Yves Pirson
Journal:  Nat Rev Nephrol       Date:  2014-06-17       Impact factor: 28.314

9.  Role of follicle-stimulating hormone on biliary cyst growth in autosomal dominant polycystic kidney disease.

Authors:  Paolo Onori; Romina Mancinelli; Antonio Franchitto; Guido Carpino; Anastasia Renzi; Stefania Brozzetti; Julie Venter; Heather Francis; Shannon Glaser; Douglas M Jefferson; Gianfranco Alpini; Eugenio Gaudio
Journal:  Liver Int       Date:  2013-04-25       Impact factor: 5.828

10.  Development and Validation of a Disease-Specific Questionnaire to Assess Patient-Reported Symptoms in Polycystic Liver Disease.

Authors:  Myrte K Neijenhuis; Tom J G Gevers; Marie C Hogan; Patrick S Kamath; Titus F M Wijnands; Ralf C P M van den Ouweland; Marie E Edwards; Jeff A Sloan; Wietske Kievit; Joost P H Drenth
Journal:  Hepatology       Date:  2016-04-15       Impact factor: 17.425
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.